Fayez A. Alghofaili
Majmaah, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Breast Milk Bioactive Components and Early-Life Epigenetic Programming: Implications for Nutrigenomics and Population Health.
Journal: Journal of the American Nutrition Association
Published: August 26, 2026
Multiple sclerosis pathophysiology: a comprehensive review of genetic, environmental, and immunological drivers.
Journal: Inflammopharmacology
Published: September 23, 2025
Correction for Alghofaili et al., "Host Stress Signals Stimulate Pneumococcal Transition from Colonization to Dissemination into the Lungs".
Journal: mBio
Published: October 28, 2024
PAI-1 influences and curcumin destabilizes MMP-2, MMP-9 and basement membrane proteins during lung injury and fibrosis.
Journal: International immunopharmacology
Published: June 07, 2024
Correlation of HbA1c Level with Lipid Profile in Type 2 Diabetes Mellitus Patients Visiting a Primary Healthcare Center in Jeddah City, Saudi Arabia: A Retrospective Cross-Sectional Study.
Journal: Diseases (Basel, Switzerland)
Published: September 13, 2023
Seroprevalence of Hepatitis A antibodies among Blood Donors at a tertiary care hospital, Saudi Arabia.
Journal: Journal of infection and public health
Published: August 08, 2023
Antibacterial efficacy of synthesized silver nanoparticles of Microbacterium proteolyticum LA2(R) and Streptomyces rochei LA2(O) against biofilm forming meningitis causing microbes.
Journal: Scientific reports
Published: November 02, 2022
Analyzing the Difference in the Length of Stay (LOS) in Moderate to Severe COVID-19 Patients Receiving Hydroxychloroquine or Favipiravir.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 14, 2022
Assessment of IL-1β, IL-6, TNF-α, IL-8, and CCL 5 levels in newly diagnosed Saudi patients with rheumatoid arthritis.
Journal: International journal of rheumatic diseases
Published: March 24, 2022
Use of bacterial culture supernatants as anti-biofilm agents against Pseudomonas aeruginosa and Klebsiella pneumoniae.
Journal: European review for medical and pharmacological sciences
Published: March 07, 2022
Last Updated: 09/26/2026